当前位置： SCI文献检索 > BMC PUBLIC HEALTH期刊下所有文献 > The rise in the number of long-term survivors from different diseases can slow the increase in life expectancy of the total population.

The rise in the number of long-term survivors from different diseases can slow the increase in life expectancy of the total population.

Abstract：

BACKGROUND:Recent improvements in life expectancy in many countries stem from reduced mortality from cardiovascular disease and cancer above the age of 60. This is the combined result of decreased incidence and improved survival among those with disease. The latter has led to a higher proportion in the population of people with a past history of disease. This is a group with higher mortality than the general population. How growing shares of persons with past history of disease and improved survival with disease have affected changes in life expectancy of the total population is the objective of this paper. METHODS:Using register data for the total Swedish population, we stratified the population based on whether individuals have been diagnosed with myocardial infarction, stroke, hip fracture, colon cancer, or breast cancer. Using a novel decomposition approach, we decomposed the changes in life expectancy at age 60 between 1994 and 2016 into contributions from improved survival with disease and from changes in proportion of people with past history of disease. RESULTS:Improvements in survival from disease resulted in gains of life expectancy for the total population. However, while the contributions to life expectancy improvements from myocardial infarction, stroke and breast cancer were substantial, the contributions from the other diseases were minor. These gains were counteracted, to various degrees, by the increasing proportion of people with raised mortality due to a past history of disease. For instance, the impact on life expectancy by improved survival from breast cancer was almost halved by the increasing share of females with a past history of breast cancer. CONCLUSION:Rising numbers of survivors of different diseases can slow the increase in life expectancy. This dynamic may represent the costs associated with successful treatment of diseases, and thus, a potential "failure of success." This dynamic should be considered when assessing mortality and life expectancy trends. As populations are aging and disease survival continues to improve, this issue is likely to become even more important in the future.

journal_name

BMC Public Health

journal_title

BMC public health

authors

Ebeling M,Meyer AC,Modig K

doi

10.1186/s12889-020-09631-3

subject

Has Abstract

pub_date

2020-10-07 00:00:00

pages

1523

issue

issn

1471-2458

pii

10.1186/s12889-020-09631-3

journal_volume

pub_type

杂志文章

在线工具

The rise in the number of long-term survivors from different diseases can slow the increase in life expectancy of the total population.